Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 10, 2014

View Archived Issues

Ubiquigent and University of Dundee form ubiquitin pathway compound library collaboration

Study finds new genes affected by MS-associated polymorphisms

Blaze Bioscience receives NCI funding for Tumor Paint BLZ-100 in sarcoma

VaxInnate plans study of VAX-2012Q in the elderly to begin by year-end

Promising initial phase I data for pramlintide/insulin fixed-dose combination

New ROR-gamma receptor modulators patented by Roche and Genentech

Vertex patents novel ATR inhibitors for cancer

Novel PDH kinase inhibitors patented at Japan Tobacco

A team of scientists in Taipai designs new polypeptides for C. difficile infection

Easy, safe and accurate local treatment of seborrheic keratosis lesions with BL-5010

Bristol-Myers Squibb reports new KCNA5 blockers

PIQUR plans phase I study of PQR-309 for relapsed or refractory lymphoma

Pathogen-specific PET tracer antibody-based molecular imaging of invasive Aspergillosis

Karolinska Institute awarded Knut and Alice Wallenberg Foundation grant

CytRx begins phase Ib trial evaluating combination of aldoxorubicin and gemcitabine

Novel DPP IV inhibitor discovered for the treatment of type 2 diabetes

Boston Therapeutics reports topline phase IIb data for BTI-320 in type 2 diabetes

Fusion Antibodies and ISCA Diagnostic complete humanization of Aspergillus-specific MAb

Amarantus reports data for Alzheimer's blood diagnostic LymPro Test

Topline results from the first part of a phase I/II trial of necuparanib in pancreatic cancer

ContraFect establishes collaborative research agreement with China CDC for CF-404

FDA approves Velcade for previously untreated mantle cell lymphoma

Capricor plans clinical program for cenderitide for post-acute heart failure

FDA accepts BLA for blinatumomab in acute lymphoblastic leukemia

Xoma initiates phase I trial of insulin receptor inhibitor antibody

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.